Cell Culture Media Market by Type (Lysogeny Broth, Serum-Free Media, Specialty Media, Classical Media, Stem Cell Media, Chemically Defined Media, Others); Application (Biopharmaceuticals, Biological Drug Discovery, Cancer Research, Tissue Engineering, Stem Cell Technologies, Other Applications); End User (Academic Institute, Research and Development Laboratory, Biotechnology Industry, Other End Users): Global Market Size Estimates and Forecast (2022-2030)
The market crossed US$ 4.52 billion mark in 2022 and is expected to hit US$ 14.25 billion by 2030, recording a CAGR of 12.7% during the forecast period.
Serum-Free Media segment held the largest share by Type Segment.
Based on the type, the cell culture media market is segmented into lysogeny broth, serum-free media, specialty media, classical media, stem cell media, chemically defined media, others. The serum free media segment held the largest share in the global cell culture media market in 2022. Serum free media offers advantages like increased productivity, better control over physiological sensitivity, more consistent performance, and reduces the risk of infection by serum-borne adventitious agents in the culture.
Within the report, the market is segmented into type, application, end user, and geography. On the basis of type, the cell culture media market is divided into lysogeny broth, serum-free media, specialty media, classical media, stem cell media, chemically defined media and others. Based on application, cell culture media market can be segmented as biopharmaceuticals, biological drug discovery, cancer research, tissue engineering, stem cell technologies and other applications. Based on end user, the cell culture media market can be segmented into academic institute, research and development laboratory, biotechnology industry and other end users. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
Cell culture is widely used for vaccine production. Cell culture is widely used to produce rotavirus, hepatitis, smallpox, rubella, polio and chickenpox vaccines. Many of the pharmaceutical companies are launching new cell-based vaccines which is likely to favor market growth. For instance, Seqirus received FDA approval for its cell-based FLUCELVAX QUADRIVALENT influenza vaccine, expanding the age indication that will include children as young as six months.
Growing biotechnology industry is likely to create growth opportunities for the market.
Cell culture and tissue culture are base of biotechnology which is likely to favor market growth. India is among the first 12 biotech hub across the globe. The industry comprises of about 5,000 biotech companies, of which 4,240 are start-ups and 760 are core biotech companies, and the number of startups is estimated to reach 10,000 by 2024.
Thus, the growing biotechnology industry is likely to favor the market growth.
Recent strategic developments in cell culture media market
The cell culture media market has undergone several significant developments, and a few of these have been mentioned below:
- In October 2021, Thermo Fisher Scientific Inc. launched the Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, that supports the large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells.
- In July 2021, Sartorius AG acquired cell culture specialist Xell AG thus strengthening its manufacturing capabilities for dry powder and liquid media.
- In March 2020, Lonza launched new TheraPEAK SfAAV medium to boost and optimize the production of aav in sf9 insect cells.
The cell culture media market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Thermo Fisher Scientific Inc., Becton, Dickinson and Company, GE Healthcare (GENERAL ELECTRIC COMPANY), Corning Incorporated, Sartorius AG, PromoCell GmbH, HiMedia Laboratories, Bio-Rad Laboratories, Inc., Sera Scandia A/S, Vitro Diagnostics Inc. are among the prominent players operating in the market.
Target audience for the report:
- Market companies
- Raw material suppliers
- Organizations, Forums, Alliances & Associations
- Product distributors
- Dealers & Suppliers And Vendors
Scope of the report:
In this report, the market has been segmented on the basis of:
- Type
- Lysogeny Broth
- Serum-Free Media
- Specialty Media
- Classical Media
- Stem Cell Media
- Chemically Defined Media
- Others
- Application
- Biopharmaceuticals
- Biological Drug Discovery
- Cancer Research
- Tissue Engineering
- Stem Cell Technologies
- Other Applications
- End-User
- Academic Institute
- Research and Development Laboratory
- Biotechnology Industry
- Other End User
- Region
- North America
- Europe
- Asia Pacific (APAC)
- South & Central America
- Middle East & Africa
- Companies profiled
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- GE Healthcare (GENERAL ELECTRIC COMPANY)
- Corning Incorporated
- Sartorius AG
- PromoCell GmbH
- HiMedia Laboratories
- Bio-Rad Laboratories, Inc.
- Sera Scandia A/S
- Vitro Diagnostics Inc.
Companies profiled
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- GE Healthcare (GENERAL ELECTRIC COMPANY)
- Corning Incorporated
- Sartorius AG
- PromoCell GmbH
- HiMedia Laboratories
- Bio-Rad Laboratories, Inc.
- Sera Scandia A/S
- Vitro Diagnostics Inc.